← All trials
NCT01924819
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2009
- Primary completion
- Dec 1, 2020
- Completion date
- Dec 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 752
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Australasian Gastro-Intestinal Trials GroupLead sponsor
- Canadian Cancer Trials GroupCollaborator
- European Organisation for Research and Treatment of CancerCollaborator
- National Health and Medical Research Council, AustraliaCollaborator
- Trans Tasman Radiation Oncology GroupCollaborator
- Peter MacCallum Cancer CentreStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.